Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 4
2022 8
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: validation, comparison and improvement of 2022 ELN genetic risk system.
Zhang H, Zheng X, Guo W, Xia Y, Zhang R, Zhai W, Chen X, Ma Q, Yang D, Wei J, Pang A, He Y, Feng S, Wang J, Han M, Jiang E. Zhang H, et al. Among authors: zheng x. Exp Hematol Oncol. 2024 Feb 15;13(1):16. doi: 10.1186/s40164-024-00487-6. Exp Hematol Oncol. 2024. PMID: 38360825 Free PMC article.
Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD.
Chen X, Zheng X, Lu N, Zhang R, Zhai W, Ma Q, Pang A, Yang D, Wei J, He Y, Feng S, Han M, Jiang E. Chen X, et al. Among authors: zheng x. Int Immunopharmacol. 2023 Dec;125(Pt A):111165. doi: 10.1016/j.intimp.2023.111165. Epub 2023 Nov 5. Int Immunopharmacol. 2023. PMID: 37935091 Free article. Review.
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms.
Zheng X, Gao H, Lu N, Wang M, Zhang H, Zheng Y, Shen B, Cao Y, Chen X, Zhai W, Wei J, Yang D, Zhang R, Pang A, Feng S, Jiang E, Han M. Zheng X, et al. Ann Hematol. 2023 Dec;102(12):3603-3611. doi: 10.1007/s00277-023-05500-2. Epub 2023 Oct 25. Ann Hematol. 2023. PMID: 37878011
Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching study.
Wang M, Zhang H, Zheng X, Liu J, Wang J, Cao Y, Zhang X, Zhang R, Chen X, Zhai W, Ma Q, Wei J, Huang Y, Yang D, He Y, Pang A, Feng S, Han M, Jiang E. Wang M, et al. Among authors: zheng x. Hematol Oncol. 2024 Jan;42(1):e3230. doi: 10.1002/hon.3230. Epub 2023 Sep 26. Hematol Oncol. 2024. PMID: 37752767
Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning.
Wang M, Guo W, Zheng X, Wang J, Liu J, Cao Y, Zhang R, Chen X, Zhai W, Ma Q, Wei J, Huang Y, Yang D, He Y, Pang A, Feng S, Han M, Jiang E. Wang M, et al. Among authors: zheng x. Bone Marrow Transplant. 2023 Jan;58(1):94-96. doi: 10.1038/s41409-022-01842-z. Epub 2022 Oct 11. Bone Marrow Transplant. 2023. PMID: 36220922 No abstract available.
27 results